Publications by Erik A. Wist
178 publications found
Original articles
The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study
Acta Oncol, 61 (5), 649-657
DOI 10.1080/0284186X.2022.2053573, PubMed 35348396
A complex communication skills training program for physicians providing advanced cancer care - content development and barriers and solutions for implementation
J Commun Healthc, 16 (1), 46-57
DOI 10.1080/17538068.2022.2039468, PubMed 36919800
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer
Int J Cancer, 147 (9), 2515-2525
DOI 10.1002/ijc.33108, PubMed 32488909
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
Genome Med, 10 (1), 92
DOI 10.1186/s13073-018-0601-y, PubMed 30497530
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
Br J Cancer, 119 (9), 1144-1154
DOI 10.1038/s41416-018-0211-x, PubMed 30401977
Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes
BMC Cancer, 18 (1), 654
DOI 10.1186/s12885-018-4568-2, PubMed 29902993
Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
Breast Cancer Res, 19 (1), 120
DOI 10.1186/s13058-017-0911-9, PubMed 29137653
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial
Breast Cancer Res Treat, 167 (3), 659-669
DOI 10.1007/s10549-017-4523-y, PubMed 29058175
Prostate and breast cancer in four Nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975-2013
Int J Cancer, 141 (11), 2228-2242
DOI 10.1002/ijc.30924, PubMed 28795403
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
Clin Cancer Res, 23 (16), 4662-4670
DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
NPJ Breast Cancer, 3, 19
DOI 10.1038/s41523-017-0015-9, PubMed 28649659
Fatigue During and After Breast Cancer Therapy-A Prospective Study
J Pain Symptom Manage, 53 (3), 551-560
DOI 10.1016/j.jpainsymman.2016.09.011, PubMed 28042070
Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes
BMC Cancer, 16 (1), 776
DOI 10.1186/s12885-016-2804-1, PubMed 27717337
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
N Engl J Med, 375 (18), 1738-1748
DOI 10.1056/NEJMoa1609709, PubMed 27717303
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
Lipids Health Dis, 15, 56
DOI 10.1186/s12944-016-0225-4, PubMed 26970778
Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings
J Cancer Surviv, 10 (5), 842-9
DOI 10.1007/s11764-016-0529-4, PubMed 26920871
Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival
Breast Cancer Res Treat, 155 (2), 345-54
DOI 10.1007/s10549-015-3671-1, PubMed 26740213
High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women
Cancer Prev Res (Phila), 8 (6), 535-44
DOI 10.1158/1940-6207.CAPR-14-0267, PubMed 25804612
Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women
Breast Cancer Res, 16 (6), 499
DOI 10.1186/s13058-014-0499-2, PubMed 25522654
Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer
J Clin Oncol, 32 (34), 3848-57
DOI 10.1200/JCO.2014.56.9327, PubMed 25366688
A randomized clinical trial of the efficacy of a self-care intervention to improve cancer pain management
Cancer Nurs, 37 (1), 34-43
DOI 10.1097/NCC.0b013e3182948418, PubMed 23666269
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
BMC Cancer, 12, 616
DOI 10.1186/1471-2407-12-616, PubMed 23259667
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336
The PRO-SELF(©) Pain Control Program improves patients' knowledge of cancer pain management
J Pain Symptom Manage, 44 (3), 321-30
DOI 10.1016/j.jpainsymman.2011.09.015, PubMed 22704056
Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
J Oncol, 2012, 862921
DOI 10.1155/2012/862921, PubMed 22291703
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
Brain Behav Immun, 25 (7), 1376-83
DOI 10.1016/j.bbi.2011.04.001, PubMed 21496483
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study
J Clin Oncol, 29 (3), 264-71
DOI 10.1200/JCO.2010.30.8213, PubMed 21149659
Predictors and course of chronic fatigue in long-term breast cancer survivors
J Cancer Surviv, 4 (4), 405-14
DOI 10.1007/s11764-010-0145-7, PubMed 20862614
A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors
J Cancer Surviv, 4 (3), 256-65
DOI 10.1007/s11764-010-0133-y, PubMed 20574815
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy
Eur Urol, 58 (1), 134-40
DOI 10.1016/j.eururo.2010.03.041, PubMed 20395037
A study of coping in long-term testicular cancer survivors
Psychol Health Med, 15 (2), 146-58
DOI 10.1080/13548501003623955, PubMed 20391232
[Survival after breast cancer--differences between Norwegian counties]
Tidsskr Nor Laegeforen, 129 (24), 2595-600
DOI 10.4045/tidsskr.09.0024, PubMed 20029554
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors
J Natl Cancer Inst, 101 (24), 1682-95
DOI 10.1093/jnci/djp413, PubMed 19940282
Fear of recurrence in long-term testicular cancer survivors
Psychooncology, 18 (6), 580-8
DOI 10.1002/pon.1437, PubMed 18855944
Adult height, insulin, and 17beta-estradiol in young women
Cancer Epidemiol Biomarkers Prev, 18 (5), 1477-83
DOI 10.1158/1055-9965.EPI-08-0972, PubMed 19423524
Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
Int J Radiat Oncol Biol Phys, 75 (3), 764-70
DOI 10.1016/j.ijrobp.2008.11.037, PubMed 19286332
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors
Acta Oncol, 48 (6), 842-9
DOI 10.1080/02841860902795232, PubMed 19412812
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
J Cancer Surviv, 2 (3), 128-37
DOI 10.1007/s11764-008-0054-1, PubMed 18792787
Chronic cancer-related fatigue in long-term survivors of testicular cancer
J Psychosom Res, 64 (4), 363-71
DOI 10.1016/j.jpsychores.2008.01.002, PubMed 18374735
Is the sexual function compromised in long-term testicular cancer survivors?
Eur Urol, 52 (5), 1438-47
DOI 10.1016/j.eururo.2007.02.046, PubMed 17350159
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
Ann Oncol, 18 (4), 694-700
DOI 10.1093/annonc/mdl488, PubMed 17301072
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Lancet, 369 (9555), 29-36
DOI 10.1016/S0140-6736(07)60028-2, PubMed 17208639
Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis
Acta Oncol, 46 (2), 153-64
DOI 10.1080/02841860601096841, PubMed 17453363
Components of the metabolic syndrome in long-term survivors of testicular cancer
Ann Oncol, 18 (2), 241-8
DOI 10.1093/annonc/mdl372, PubMed 17060482
Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
Int J Cancer, 118 (11), 2877-81
DOI 10.1002/ijc.21709, PubMed 16381016
Paternity following treatment for testicular cancer
J Natl Cancer Inst, 97 (21), 1580-8
DOI 10.1093/jnci/dji339, PubMed 16264178
Blood pressure and body mass index in long-term survivors of testicular cancer
J Clin Oncol, 23 (22), 4980-90
DOI 10.1200/JCO.2005.06.882, PubMed 16051950
Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer
J Clin Oncol, 23 (13), 3061-8
DOI 10.1200/JCO.2005.08.048, PubMed 15860864
Study of anxiety disorder and depression in long-term survivors of testicular cancer
J Clin Oncol, 23 (10), 2389-95
DOI 10.1200/JCO.2005.05.061, PubMed 15800331
The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample
Support Care Cancer, 13 (8), 637-46
DOI 10.1007/s00520-004-0769-0, PubMed 15756585
[Should complementary therapies be offered in hospitals?]
Tidsskr Nor Laegeforen, 124 (23), 3078-80
PubMed 15586193
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway
Eur J Cancer, 40 (4), 529-35
DOI 10.1016/j.ejca.2003.11.011, PubMed 14962719
Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway
Support Care Cancer, 12 (5), 312-8
DOI 10.1007/s00520-004-0590-9, PubMed 14767750
Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer
Acta Oncol, 43 (2), 186-9
DOI 10.1080/02841860310023165, PubMed 15163168
Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer
Acta Oncol, 43 (1), 11-4
DOI 10.1080/02841860310017748, PubMed 15068314
[Should alternative therapists treat cancer--what is the opinion of oncology health personnel?]
Tidsskr Nor Laegeforen, 123 (21), 3059-61
PubMed 14618177
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer
Eur Urol, 44 (3), 322-8
DOI 10.1016/s0302-2838(03)00263-x, PubMed 12932930
The level of physical activity in long-term survivors of testicular cancer
Eur J Cancer, 39 (9), 1216-21
DOI 10.1016/s0959-8049(03)00151-5, PubMed 12763208
[Does use of alternative medicine aggravate the survival prognosis in cancer?]
Tidsskr Nor Laegeforen, 123 (5), 628-30
PubMed 12683189
Does use of alternative medicine predict survival from cancer?
Eur J Cancer, 39 (3), 372-7
DOI 10.1016/s0959-8049(02)00701-3, PubMed 12565991
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
Br J Cancer, 86 (12), 1905-8
DOI 10.1038/sj.bjc.6600325, PubMed 12085184
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
Eur J Cancer, 38 (4), 535-42
DOI 10.1016/s0959-8049(01)00403-8, PubMed 11872346
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer
Clin Cancer Res, 8 (3), 811-6
PubMed 11895913
Physical performance, toxicity, and quality of life as assessed by the physician and the patient
Acta Oncol, 41 (1), 44-9
DOI 10.1080/028418602317314055, PubMed 11990517
[Terminal care of cancer patients]
Tidsskr Nor Laegeforen, 121 (22), 2590-2
PubMed 11668754
Cutaneous relapse of testicular embryonic carcinoma
J Urol, 165 (3), 909
DOI 10.1016/S0022-5347(05)66565-2, PubMed 11176507
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study
Lancet, 356 (9239), 1384-91
DOI 10.1016/s0140-6736(00)02841-5, PubMed 11052580
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer
Clin Cancer Res, 6 (8), 3103-10
PubMed 10955790
Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group
Eur J Cancer, 35 (8), 1194-201
DOI 10.1016/s0959-8049(99)00122-7, PubMed 10615229
[Well-educated and healthy]
Tidsskr Nor Laegeforen, 119 (11), 1576
PubMed 10385797
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial
Eur J Cancer, 34 (9), 1368-74
DOI 10.1016/s0959-8049(98)00068-9, PubMed 9849419
[Cancer patients' perception of the examination period prior to treatment]
Tidsskr Nor Laegeforen, 118 (16), 2468-70
PubMed 9667121
Patients' opinion and use of non-proven therapies related to their view on cancer aetiology
Anticancer Res, 18 (1B), 499-505
PubMed 9568169
Influence of droloxifene on metastatic breast cancer as first-line endocrine treatment
Acta Oncol, 37 (4), 365-8
DOI 10.1080/028418698430584, PubMed 9743458
Cancer patients use of nonproven therapy: a 5-year follow-up study
J Clin Oncol, 16 (1), 6-12
DOI 10.1200/JCO.1998.16.1.6, PubMed 9440716
[Breast cancer treated at the oncologic department, University Hospital in Tromsø 1986-94]
Tidsskr Nor Laegeforen, 117 (26), 3786-9
PubMed 9417681
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study
Eur J Cancer, 33 (10), 1551-8
DOI 10.1016/s0959-8049(97)00102-0, PubMed 9389914
Lumpectomy or mastectomy? Is breast conserving surgery too expensive?
Breast Cancer Res Treat, 45 (1), 7-14
DOI 10.1023/a:1005804101106, PubMed 9285112
Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group
Br J Surg, 84 (8), 1130-5
DOI 10.1002/bjs.1800840827, PubMed 9278661
[Use of alternative medicine among Norwegian hospitalized cancer patients]
Tidsskr Nor Laegeforen, 117 (17), 2458-63
PubMed 9265305
Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer
Eur J Cancer, 33 (7), 1038-44
DOI 10.1016/s0959-8049(97)00041-5, PubMed 9376184
Communicating with and treating cancer patients: how does the use of non-proven therapies and patients' feeling of mental distress influence the interaction between the patient and the hospital staff
Eur J Cancer, 33 (6), 883-90
DOI 10.1016/s0959-8049(97)00025-7, PubMed 9291810
Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway
Eur J Cancer, 33 (4), 575-80
DOI 10.1016/s0959-8049(96)00504-7, PubMed 9274437
[Hodgkin disease treated at the Tromsø regional hospital 1985-93. Diagnosis, treatment, prognosis, quality of life and costs of a decentralized treatment]
Tidsskr Nor Laegeforen, 117 (1), 23-6
PubMed 9064805
[Attitudes to treatment with cytostatic agents. Do cancer patients, physicians, nurses and healthy individuals vary in their views?]
Tidsskr Nor Laegeforen, 116 (21), 2583-7
PubMed 8928131
[High dose therapy with autologous stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services]
Tidsskr Nor Laegeforen, 116 (21), 2577-81
PubMed 8928130
Treatment costs in Hodgkin's disease: a cost-utility analysis
Eur J Cancer, 32A (9), 1510-7
DOI 10.1016/0959-8049(96)00142-6, PubMed 8911110
Quality of life in survivors of Hodgkin's disease
Qual Life Res, 5 (3), 367-74
DOI 10.1007/BF00433921, PubMed 8763805
Psychological distress in survivors of Hodgkin's disease
Support Care Cancer, 4 (3), 191-5
DOI 10.1007/BF01682339, PubMed 8739651
Delay in diagnosis and treatment of breast cancer in northern Norway
Oncol Rep, 3 (3), 571-4
DOI 10.3892/or.3.3.571, PubMed 21594415
Spiritual healing among Norwegian hospitalised cancer patients and patients' religious needs and preferences of pastoral services
Eur J Cancer, 32A (2), 274-81
DOI 10.1016/0959-8049(95)00516-1, PubMed 8664041
Palliative chemotherapy in metastatic colorectal carcinoma: comparison of two chemotherapeutic regimens
Anticancer Res, 16 (2), 921-6
PubMed 8687152
Treatment intention in hospitalized cancer patients in oncological wards in Norway: a national survey
Cancer Treat Rev, 22 Suppl A, 33-9
DOI 10.1016/s0305-7372(96)90061-4, PubMed 8625347
Diagnostic delay causes more psychological distress in female than in male cancer patients
Anticancer Res, 16 (2), 995-9
PubMed 8687166
ChlVPP is as effective as alternating ChlVPP/ABOD in advanced stage Hodgkin's disease
Acta Oncol, 35 Suppl 8, 73-80
DOI 10.3109/02841869609098523, PubMed 9073051
The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy
Eur J Cancer, 31A (13-14), 2260-3
DOI 10.1016/0959-8049(95)00296-0, PubMed 8652253
Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy
Eur J Cancer, 31A (12), 1955-9
DOI 10.1016/0959-8049(95)00513-7, PubMed 8562147
The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study
Eur J Cancer, 31A (11), 1785-9
DOI 10.1016/0959-8049(95)00328-g, PubMed 8541101
[Testicular cancer treated at the regional hospital in Tromsø 1985-1993]
Tidsskr Nor Laegeforen, 115 (14), 1715-7
PubMed 7785028
Subclassification of Hodgkin's disease, nodular sclerosis type. Prognostic value?
Anticancer Res, 15 (4), 1569-72
PubMed 7654047
Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer
Acta Oncol, 34 (7), 893-8
DOI 10.3109/02841869509127201, PubMed 7492377
Testicular cancer treated in a minor general oncology department
Eur J Cancer, 31A (3), 293-5
DOI 10.1016/0959-8049(94)00448-e, PubMed 7540400
Weekly doxorubicin with or without high-dose medroxyprogesterone acetate in hormone-resistant advanced breast cancer. A randomised study. The Norwegian Breast Cancer Group
Eur J Cancer, 30A (12), 1775-8
DOI 10.1016/0959-8049(94)00213-o, PubMed 7880604
Gender difference in red blood cell thiopurine methyltransferase activity
Scand J Clin Lab Invest, 53 (7), 747-9
DOI 10.3109/00365519309092580, PubMed 8272762
Psychological distress in cancer patients with advanced disease
Radiother Oncol, 27 (3), 193-7
DOI 10.1016/0167-8140(93)90073-h, PubMed 7692472
[Spontaneous cancer remission]
Tidsskr Nor Laegeforen, 113 (12), 1497-8
PubMed 8332985
[When a cancer patient dies at home--experience of the relatives]
Tidsskr Nor Laegeforen, 113 (9), 1107-9
PubMed 8493682
Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population
Eur J Clin Pharmacol, 44 (2), 147-52
DOI 10.1007/BF00315472, PubMed 8453958
Teaching communication with cancer patients and terminally ill patients to medical students
J Cancer Educ, 8 (2), 119-22
DOI 10.1080/08858199309528217, PubMed 8363937
[Intestinal lymphoma presented as multiple intestinal polyposis]
Tidsskr Nor Laegeforen, 112 (15), 1956-7
PubMed 1509456
[Accidents with radioactive pollution. Can we do something?]
Tidsskr Nor Laegeforen, 112 (10), 1314-6
PubMed 1374574
Interethnic difference in thiopurine methyltransferase activity
Clin Pharmacol Ther, 51 (1), 24-31
DOI 10.1038/clpt.1992.4, PubMed 1732075
Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer
Acta Oncol, 31 (4), 425-8
DOI 10.3109/02841869209088284, PubMed 1632978
[Treatment of advanced anal cancer]
Nord Med, 107 (8-9), 227-8
PubMed 1408730
The effect of vindesine on methotrexate hydroxylation in the rat
Biochem Pharmacol, 42 (8), 1561-8
DOI 10.1016/0006-2952(91)90425-5, PubMed 1930283
[Infusor--an aid in cytostatic therapy]
Tidsskr Nor Laegeforen, 111 (16), 1979-80
PubMed 1866732
[Merkel cell carcinoma]
Tidsskr Nor Laegeforen, 111 (14), 1723-4
PubMed 2063380
Inhibition of 7-hydroxymethotrexate formation by amsacrine
Cancer Chemother Pharmacol, 28 (5), 377-83
DOI 10.1007/BF00685693, PubMed 1914082
Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma
Eur J Cancer, 27 (5), 576-9
DOI 10.1016/0277-5379(91)90221-x, PubMed 1828964
Trofosfamide in non-Hodgkin's lymphoma. A phase II study
Acta Oncol, 30 (7), 819-21
DOI 10.3109/02841869109091828, PubMed 1764273
[Cerebral metastasis in Hodgkin's disease]
Tidsskr Nor Laegeforen, 110 (25), 3240-1
PubMed 2256037
[Chylothorax]
Tidsskr Nor Laegeforen, 110 (23), 3017-8
PubMed 2237855
[Alltime pain relief?]
Tidsskr Nor Laegeforen, 110 (5), 581
PubMed 1689876
Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo
Cancer Res, 49 (22), 6359-64
PubMed 2804982
Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration
Cancer Res, 49 (9), 2460-4
PubMed 2706634
Stage III Hodgkin's disease--long-term results following chemotherapy, radiotherapy and combined modality therapy
Radiother Oncol, 14 (3), 185-98
DOI 10.1016/0167-8140(89)90166-7, PubMed 2710949
[High dose melphalan and autologous bone marrow transplantation in the treatment of small cell carcinoma of the lung]
Tidsskr Nor Laegeforen, 108 (27), 2271-4
PubMed 2849815
[How do physicians deliver sad messages?]
Nord Med, 102 (11), 321-2
PubMed 3697052
Changing aspects in the treatment of squamous cell carcinoma of the oral tongue
Acta Oncol, 26 (3), 163-72
DOI 10.3109/02841868709091424, PubMed 3651261
[Treatment of advanced squamous cell carcinoma of the maxillary sinus]
Tidsskr Nor Laegeforen, 106 (7), 572-6
PubMed 3961784
Effect of the radioprotector WR 2721 on the response of metastatic Lewis lung carcinoma colonies to alkylating agents
Acta Radiol Oncol, 24 (3), 259-62
DOI 10.3109/02841868509134397, PubMed 2994377
[Pelvic lipomatosis]
Tidsskr Nor Laegeforen, 104 (17-18), 1228-9
PubMed 6740618
[Kaposi's sarcoma]
Tidsskr Nor Laegeforen, 104 (7), 495-8
PubMed 6729784
[Pathological liver function tests due to trimethoprim-sulfamethoxazole]
Tidsskr Nor Laegeforen, 102 (22), 1080-1
PubMed 7164063
The modification of melphalan toxicity in tumor bearing mice by s-2-(3-aminopropylamino)- ethylphosphorothioic acid (WR 2721)
Am J Clin Oncol, 5 (3), 321-8
DOI 10.1097/00000421-198206000-00015, PubMed 6282111
An explanation for the ability of cytotoxic drug pretreatment to reduce bone marrow related lethality of total body irradiation (TBI)
Int J Radiat Oncol Biol Phys, 8 (3-4), 581-3
DOI 10.1016/0360-3016(82)90688-5, PubMed 7050041
The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer
Int J Radiat Oncol Biol Phys, 8 (3-4), 387-9
DOI 10.1016/0360-3016(82)90645-9, PubMed 7107357
Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism
Nucleic Acids Res, 9 (18), 4709-19
DOI 10.1093/nar/9.18.4709, PubMed 6795595
Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts
Br J Cancer, 43 (4), 458-63
DOI 10.1038/bjc.1981.67, PubMed 6263305
Effects of araC and aphidicolin on DNA chain elongation rate in HeLa S3 cells
Experientia, 36 (4), 405-6
DOI 10.1007/BF01975113, PubMed 6769693
Partial purification of deoxyuridine triphosphate nucleotidohydrolase and its effect on DNA synthesis in isolated HeLa cell nuclei
Biochim Biophys Acta, 565 (1), 98-106
DOI 10.1016/0005-2787(79)90085-6, PubMed 508767
No stimulatory effect of added histones on DNA synthesis in isolated HeLa cell nuclei
Mol Biol Rep, 5 (3), 189-91
DOI 10.1007/BF00778422, PubMed 492163
The effect of aphidicolin on DNA synthesis in isolated HeLa cell nuclei
Nucleic Acids Res, 6 (4), 1583-90
DOI 10.1093/nar/6.4.1583, PubMed 450707
The role of DNA polymerases alpha, beta and gamma in nuclear DNA synthesis
Biochim Biophys Acta, 562 (1), 62-9
DOI 10.1016/0005-2787(79)90126-6, PubMed 435500
Preservation by glycerol of DNA synthetic capacity of isolated HeLa S(3) cell nuclei during long term storage at low temperature
Exp Cell Res, 116 (2), 313-6
DOI 10.1016/0014-4827(78)90453-6, PubMed 710528
Accumulation of small fragments of DNA in isolated HeLa cell nuclei due to transient incorporation of dUMP
Biochim Biophys Acta, 520 (2), 253-70
DOI 10.1016/0005-2787(78)90225-3, PubMed 708736
DNA replication intermediates in whole HeLa cells and isolated nuclei
Biochim Biophys Acta, 475 (4), 553-61
DOI 10.1016/0005-2787(77)90316-1, PubMed 851539
Effect of cytosol on DNA synthesis in isolated HeLa cell nuclei
Biochem Biophys Res Commun, 75 (2), 414-9
DOI 10.1016/0006-291x(77)91058-0, PubMed 851447
Effect of 1-beta-D-arabinofuranosylcytosine triphosphate on DNA synthesis in isolated HeLa cell nuclei
Biochemistry, 15 (16), 3647-52
DOI 10.1021/bi00661a036, PubMed 952882
Review articles
Cardiotoxic effects of trastuzumab
Tidsskr Nor Laegeforen, 131 (22), 2239-41
DOI 10.4045/tidsskr.10.0862, PubMed 22085949
Primary retroperitoneal sarcomas. A review of 36 cases
Acta Radiol Oncol, 24 (4), 305-10
DOI 10.3109/02841868509136056, PubMed 2994385
Other articles
FOOD AGAINST CANCER
Tidsskr. Nor. Laegeforen., 139 (9), 861
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer (vol 3, 35, 2017)
npj Breast Cancer, 3, 35
DOI 10.1038/s41523-017-0030-x
Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
NPJ Breast Cancer, 3, 35
DOI 10.1038/s41523-017-0030-x, PubMed 28884144
[Is comorbidity a prognostic factor in premenopausal women with breast cancer?]
Tidsskr Nor Laegeforen, 121 (9), 1023
PubMed 11354873
Gd-DTPA enhanced MR imaging in the management of residual mediastinal tumours in malignant lymphoma and thymoma
Cancer J., 9 (1), 56-57
The Ch1VPP regimen, a risk factor for herpes zoster virus infection in patients treated for Hodgkin's disease
Eur J Haematol, 53 (1), 51-3
DOI 10.1111/j.1600-0609.1994.tb00180.x, PubMed 8062898
Treatment of Hodgkin's disease in a small oncological unit
Eur J Haematol, 50 (5), 297-8
DOI 10.1111/j.1600-0609.1993.tb00166.x, PubMed 8319791
Topical capsaicin in treatment of hyperalgesia, allodynia and dysesthetic pain caused by malignant tumour infiltration of the skin
Acta Oncol, 32 (3), 343
DOI 10.3109/02841869309093606, PubMed 8323774
[Admission criteria for medical studies]
Tidsskr Nor Laegeforen, 112 (10), 1338
PubMed 1579925
Cerebral metastases from multiple myeloma
Acta Oncol, 30 (7), 868-9
DOI 10.3109/02841869109091837, PubMed 1764277
Incomplete Currarino syndrome with a presacral leiomyosarcoma
Acta Oncol, 30 (8), 987-8
DOI 10.3109/02841869109088256, PubMed 1777251
Books
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo (3. utg.), 441 s.
BIBSYS 080553532, ISBN 978-82-05-38485-9
Antikreft
Pantagruel forl., Oslo, 96 s.
BIBSYS 082709505, ISBN 978-82-7900-331-1
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo (2. utg.), 416 s.
BIBSYS 050216910, ISBN 978-82-05-33494-6
Tarmkreft: informasjon om tarmkreft for pasienter pårørende og andreinteresserte
In Kreftinfo, Den norske kreftforening, Oslo, 6/2002 (4. oppl.), 25 s.
BIBSYS 030466571
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo, 400 s.
BIBSYS 000586978, ISBN 82-00-45260-3
Brystkreft: en informasjonsbok for pasienter og pårørende
Universitetsforl., Oslo, 170 s.
BIBSYS 982362595, ISBN 82-00-42576-2
Palliativ strålbehandling
Studentlitteratur, Lund, 189 s.
BIBSYS 962432091, ISBN 91-44-39771-2
CD e RiTøelt: RiTø-revyen 1995
[Regionsykehuset i Tromsø], [Tromsø], 60 s.
BIBSYS 092366422
Stråleterapi i Norge: innstilling avgitt 17.3.92
In Helsedirektoratets utredningsserie, [Direktoratet], [Oslo], 2-93, 37 s.
BIBSYS 931341388
Palliativ strålebehandling
Universitetsforlaget, Oslo, 179 s.
BIBSYS 921112025, ISBN 82-00-40691-1
Kreftforekomst i Nord-Norge
Kreftregisteret, Oslo, 120 s.
BIBSYS 874051134, ISBN 82-90343-15-9
Book chapters
Brystkreft
In Kreftsykepleie pasient - utfordring - handling, Akribe Forlag, Oslo, Norge, 431-439
PublikaID 78, ISBN 978-82-7950-144-2
Brystkreft
In Medikamentell kreftbehandling, Farmakologisk institutt, Det medisinske fakultet, Universitetet i Oslo, 357-362
PublikaID 79, ISBN 978-829923312-5
Alternativ og komplementær behandling
In Palliasjon: nordisk lærebok, Gyldendal akademisk, Oslo, S. 179-193
BIBSYS 080210201
Onkologiske akuttilstander
In Kreftsykdommer - en basisbok for helsepersonell (Wist EA, ed.), Gyldendal Akademisk, Oslo, Norway
PublikaID 80, ISBN 82-05-33494-3
Theses
Studies on DNA replication in HeLa cells
Institute of Medical Biology, University of Tromsø, Tromsø, 1 b. (fl. pag.)
BIBSYS 812114493